NovaPharm is a late stage drug development company focused on new treatments for Complex Regional Pain Syndrome
Orphan drug, breakthrough designation, phase 3
Mike co founded NovaPharm in 2011 after 25+ years in the pharmaceutical, biotech and consumer products industries. The company is in phase 3 with its primary asset.
Paul co founded NovaPharm and with over 30 years of experience in preclinical and clinical drug development, Paul has been instrumental in leading the successful development of the company's lead compounds.
Greg joined NovaPharm in 2016 bringing a wealth of regulatory experience across multiple therapeutic areas.
Marco was an original founding member of NovaPharm in 2011. He remains an active member of the Board and provides scientific and medical oversight to the company.
Copyright © 2019 - All Rights Reserved.
Powered by NPT